WHO ICTRP trial
A Phase 1 Study to Evaluate the Effect of Multiple Doses of Rabeprazole on the…
ACTRN12624000878572 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12624000878572 |
|---|---|
| Public title | A Phase 1 Study to Evaluate the Effect of Multiple Doses of Rabeprazole on the Pharmacokinetics of a Single Dose of Radiprodil in Healthy Adult Participants |
| Scientific title | A Phase 1, Fixed Sequence, Open-Label Study to Evaluate the Effect of Multiple Doses of Rabeprazole on the Pharmacokinetics of a Single Dose of Radiprodil in Healthy Adult Participants |
| Primary sponsor | GRIN Therapeutics, Inc. |
| Secondary sponsors | Avance Clinical Pty Ltd |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Australia |
| Conditions | Malformations of Cortical Development; Malformations of Cortical Development;Neurological - Other neurological disorders;Human Genetics and Inherited Disorders - Other human genetics and inherited disorders |
| Interventions | This is a Phase 1, fixed sequence, open-label study to evaluate the effect of multiple oral doses of rabeprazole (20 mg once daily) on the pharmacokinetics (PK) of a single dose (45 mg) of radiprodil in healthy adult participants… |
| Registration date | Jul 18, 2024 |
| Target size | 18 |
| Secondary IDs | RAD-GRIN-502 |
| Registry page | anzctr.org.au |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: